Lemesle Gilles, Sudre Arnaud, Modine Thomas, Delhaye Cédric, Rosey Guillaume, Gourlay Terry, Bauters Christophe, Lablanche Jean-Marc
Service de Cardiologie B et Centre Hémodynamique, Hôpital cardiologique, CHRU de LILLE, 59037 Lille, France.
Catheter Cardiovasc Interv. 2008 Oct 1;72(4):470-8. doi: 10.1002/ccd.21709.
We attempted to investigate incidence and predictors of recurrent in stent thrombosis (IST) after successful treatment of a first IST.
The occurrence of recurrent IST after successful treatment of a first IST may be a decisive factor for patient clinical outcome. However, incidence and predictors of recurrent IST are currently poorly described in the literature.
Between 2003 and 2005, 2,190 patients underwent a percutaneous coronary intervention in our center. During a median follow-up of 19.4 months, 49 patients (2.24%) presented a first definite IST. Patients presenting with a first IST were followed during an additional median period of 40 months. Their baseline characteristics were listed and cardiovascular events especially recurrent IST as defined by the Academic Research Consortium definition were systematically indexed.
Altogether 39 (80%) patients were successfully treated with an effective reperfusion after percutaneous coronary intervention. Fourteen (36%) patients presented a recurrent IST and three presented multiple recurrent IST. The median occurrence time of recurrent IST was 5 days, range between 1 and 11 days. Multivariate analysis identified history of neoplasia (HR = 11.53, 95% CI 2.32-57.37, P = 0.003), residual diameter stenosis (HR = 1.15, 95% CI 1.02-1.29, P = 0.02), and residual dissection after treatment (HR = 8.78, 95% CI 1.85-41.62, P = 0.006), as independent predictors of recurrent IST.
Recurrent IST is a frequent and early event after successful treatment of a first IST. Our results suggest that mechanical factors like residual dissection and residual diameter stenosis should be carefully tracked down. In addition, patients with multiple recurrent IST and the early time course of recurrent IST also suggest a potential role of inadequate antiplatelet therapy.
我们试图研究首次支架内血栓形成(IST)成功治疗后复发性IST的发生率及预测因素。
首次IST成功治疗后复发性IST的发生可能是决定患者临床结局的一个因素。然而,目前文献中对复发性IST的发生率及预测因素描述甚少。
2003年至2005年期间,我们中心有2190例患者接受了经皮冠状动脉介入治疗。在中位随访19.4个月期间,49例患者(2.24%)出现首次明确的IST。出现首次IST的患者在额外的中位40个月期间接受随访。列出他们的基线特征,并系统记录心血管事件,尤其是学术研究联盟定义的复发性IST。
共有39例(80%)患者在经皮冠状动脉介入治疗后通过有效的再灌注成功治疗。14例(36%)患者出现复发性IST,3例出现多次复发性IST。复发性IST的中位发生时间为5天,范围在1至11天之间。多变量分析确定肿瘤病史(HR = 11.53,95% CI 2.32 - 57.37,P = )、残余直径狭窄(HR = 1.15,95% CI 1.02 - 1.29,P = 0.02)以及治疗后残余夹层(HR = 8.78,95% CI 1.85 - 41.62,P = 0.006)为复发性IST的独立预测因素。
首次IST成功治疗后,复发性IST是一种常见且早期发生的事件。我们的结果表明,应仔细追查残余夹层和残余直径狭窄等机械因素。此外,多次复发性IST的患者以及复发性IST的早期病程也提示抗血小板治疗不足可能起了作用。 (注:原文中肿瘤病史HR值对应P值处缺失数据)